Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults.
The New England journal of medicine · 2021 · 199 citations · Nicole Grunenberg
Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 24 citations · Lindsay Gunnell
Adult cervical spine deformity: a state-of-the-art review.
Spine deformity · 2024 · 7 citations · Brendan Jackson-Fowl
Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk.
The Journal of infectious diseases · 2022 · 45 citations · Nicole Grunenberg
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study.
The Lancet. Infectious diseases · 2022 · 58 citations · Nicole Grunenberg
An HIV-1 gp41 peptide-liposome vaccine elicits neutralizing epitope-targeted antibody responses in healthy individuals.
medRxiv : the preprint server for health sciences · 2025 · 9 citations ·
Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk.
PLoS pathogens · 2021 · 29 citations · Nicole Grunenberg
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial.
The Lancet. Respiratory medicine · 2023 · 25 citations · Nicole Grunenberg